Endogenous levels of 5 alpha-reduced progestins and androgens in fetal vs. adult rat brains

Developmental Brain Research

Volumn 115, Issue 1, 1999, Pages 17-24

  Kellogg, Carol K ^a   Frye, Cheryl A ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Brain development; Neurosteroid; Non genomic; Progesterone; Testosterone

Indexed keywords

ANDROGEN; GESTAGEN; OXIDOREDUCTASE; STEROID;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN LEVEL; ENZYME ACTIVITY; FEMALE; GESTATIONAL AGE; HORMONE DETERMINATION; HORMONE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANDROGENS; ANIMALS; BRAIN; FEMALE; MALE; PROGESTINS; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE 5-ALPHA-REDUCTASE;

ANIMALIA;

EID: 0033535972     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(99)00041-3     Document Type: Article

References (43)

1. Baulieu E-E., Robel P. Neurosteroids: a new brain function. J. Steroid Biochem. Mol. Biol. 37:1990;395-403.
2. A receptor. Brain Res. 561:1991;157-161.
3. R.D. Brinton, The neurosteroid 3α-hydroxy-5α-pregnane-20-one induces cytoarchitectural regression in cultured fetal hippocampal neurons. J. Neurosci. 14 (1994) 2763-2774.
4. A receptors. Eur. J. Pharmacol. 325:1997;1-7.
5. Cherbini E., Gaiarsa J.L., Ben-Ari Y. GABA: an excitatory transmitter in early postnatal life. Trends Neurosci. 14:1991;515-519.
6. Compagnone N.A., Bulfone A., Rubenstein J.L.R., Mellon S.H. Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology. 136:1995;2689-2696.
7. Corbier P., Kerdelhue B., Picon R., Roffi J. Changes in testicular weight and serum gonadotropin and testosterone levels before, during, and after birth in the perinatal rat. Endocrinology. 103:1978;985-992.
8. Erskine M., Hippensteil N., Kornberg E. Metabolism of dihydrotestosterone to 3α-androstanediol in brain and plasma: effect on behavioural activity in female rats. J. Endocrinol. 134:1992;183-195.
9. Finn D.A., Gee K.W. The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J. Pharmacol. Exp. Ther. 271:1994;164-170.
10. Frye C.A. The neurosteroid 3α,5α-THP has anti-seizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696:1995;113-120.
11. Frye C.A., Bayon L.E. Seizure activity is increased in endocrine states characterized by decline in endogenous 3α,5α-THP. Neuroendocrinology. 68:1998;272-280.
12. C.A. Frye, L.E. Bayon, Pregnane and androstane neurosteroids are increased in mated rats and across various hormonal and reproductive milieru, J. Neuroendocrinol. (in press).
13. Frye C.A., van Keuran K.R., Erskine M.S. Behavioral effects of 3α-androstandiol: I. Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79:1996;109-118.
14. Frye C.A., Scalise T.J., Bayon L.E. Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J. Neuroendocrinol. 10:1998;291-296.
15. Frye C.A., McCormick C.M., Coopersmith C., Erskine M.S. Effects of paced and non-paced mating stimulation on plasma progesterone, 3α-diol and corticosterone. Psychoneuroendocrinology. 21:1996;431-439.
16. Frye C.A., Duncan J.E., Basham M., Erskine M.E. Behavioral effects of 3α-androstanediol: II. Hypothalamic and preoptic area actions via GABAergic mechanism. Behav. Brain Res. 79:1996;119-130.
17. Frye C.A., van Keuran K.R., Rao P.N., Erskine M.S. Progesterone and 3α-androstanediol conjugated to bovine serum albumin affects estrous behavior when applied to the MBH and POA. Behav. Neurosci. 110:1996;603-612.
18. Gee K.W., Bolger M.B., Brinton R.D., Coirini H., McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246:1988;803-812.
19. Hu Z.Y., Bourreau E., Jungo-Testas I., Robel P., Baulieu E-E. Oligodendrocyte mitochondria convert cholesterol to pregnenolone. Proc. Natl. Acad. Sci. U.S.A. 84:1987;8129-8215.
20. Hutchison J.B., Steimer T. Androgen metabolism in the brain: behavioural correlates. Prog. Brain Res. 61:1984;23-51.
21. Hutchison J.B., Beyer C., Hutchison R.E., Wozniak A. Sex differences in the regulation of embryonic brain aromatase. J. Steroid Biochem. Mol. Biol. 61:1997;315-322.
22. Jung-Testas I., Hu Z.Y., Robel P., Baulieu E-E. Biosynthesis of pregnanolone and progesterone in primary cultures of rat glial cells. Endocrinology. 125:1989;2083-2091.
23. A receptor in fetal rat forebrain. Dev. Brain Res. 108:1998;131-137.
24. A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
25. Lauber M.E., Lichtensteiger W. Ontogeny of 5α-reductase (type 1) messenger ribonucleic acid expression in rat brain: early presence in germinal zones. Endocrinology. 137:1996;2718-2730.
26. Lephart E.D. Brain 5α-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function. Mol. Cell. Neurosci. 4:1993;473-484.
27. F.M. Leslie, Neurotransmitters as neurotrophic factors, in: S.E. Loughlin, J.H. Fallon (Eds.), Neurotrophic Factors, Academic Press, San Diego, 1993, pp. 565-598.
28. Long J.A., Evans H.M. Oestrus cycle in the rat and its associated phenomena. Memoirs Univ. California. 6:1922;1-146.
29. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
30. Matt D.W., McDonald G.J. In vitro progesterone and testosterone production by the rat placenta during pregnancy. Endocrinology. 115:1984;741-747.
31. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:1991;141-147.
32. Naftolin R. Brain aromatization of androgens. J. Reprod. Med. 39:1994;257-261.
33. K. Normington, D.W. Russell, Tissue distribution and kinetic characteristics of rat steroid 5a-reductase isozymes, J. Biol. Chem. 267 19548-19554.
34. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;51-63.
35. D. Rodbard, D. M. Hutt, Statistical analysis of radioimmunoassay and immunoradiometric assays: a generalized, weighted iterative, least squares method for logistic curve fitting, in: International Atomic Energy Agency (Ed.), Symposium on Radioimmunoassay and Related Procedures in Medicine, Uniput, New York, 1974.
36. Rupprecht R., Hauser C.A.E., Trapp T., Holsboer F. Neurosteroids: molecular mechanisms of action and psychopharmacological significance. J. Steroid Biochem. Mol. Biol. 56:1996;163-168.
37. Singer W. Neurophysiology: the changing face of inhibition. Curr. Biol. 6:1996;395-397.
38. Smith S.S., Woodward D.J., Chapin J.K. Sex steroids modulate motor-correlated increases in cerebellar discharge. Brain Res. 476:1989;307-316.
39. A receptor α4 subunit in association with increased anxiety. J. Neurosci. 18:1998;5275-5284.
40. Ukena K., Usui M., Kohchi C., Tsutsui K. Cytochrome P450 side-chain cleavage enzyme in the cerebellar purkinje neuron and its neonatal change in rats. Endocrinology. 139:1998;137-147.
41. Wagner C.K., Nakayama A.T., De Vries G.J. Potential role of maternal progesterone in the sexual differentiation of the brain. Endocrinology. 139:1998;3658-3661.
42. Weisz J., Ward I.L. Plasma testosterone and progesterone titers of pregnant rats, their male and female fetuses, and neonatal offspring. Endocrinology. 106:1980;306-316.
43. Yu R., Ticku M.K. Chronic neurosteroid treatment produces functional heterologous uncoupling at the γ-aminobutyric acid type A/benzodiazepine receptor complex in mammalian cortical neurons. Mol. Pharmacol. 47:1995;603-610.